Answers are grounded in this paper and cite their sources.
The first golden era of cancer drug development was initiated in the 1940s and gave rise to the cytotoxic agents that dominate current cancer medicine. The second golden era is now underway in which cancer genomics will direct drug development.
No takes yet. Share an insight, caveat, or question.
Paul Workman (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: